« Previous
Next »
Journal of the American Academy of Dermatology
Volume 61, Issue 1
, Pages
112-116
, July 2009
A novel regimen of vorinostat with interferon gamma for refractory Sézary syndrome
To access this article, please choose from the options below
Funding sources: None.
Disclosure: Dr Rook has lectured at events sponsored by Merck. Dr Kim was a study site investigator for a clinical trial involving vorinostat from 2004 to 2005. Drs Gardner, Introcaso, Nasta, and Vittorio have no conflicts of interest to declare.
Reprints not available from the authors.
PII: S0190-9622(08)02460-2
doi: 10.1016/j.jaad.2008.11.889
© 2009 American Academy of Dermatology, Inc. Published by Elsevier Inc All rights reserved.
« Previous
Next »
Journal of the American Academy of Dermatology
Volume 61, Issue 1
, Pages
112-116
, July 2009
